glp-1 and alzheimer's drugs failed to slow in two big clinical trials Weight-Loss Drugs May Reduce Buildup

Ozempic is typically administered once a week via an injection, while other GLP-1 medications may have different dosing intervals

Debatri Datta Medically Reviewed By Dr

Treatments launched in the past several years by companies including Eli Lilly and an Eisai-Biogen partnership are the first drugs ever shown to slow cognitive decline in people with Alzheimers after years of failed trials, but they require infusions or injections and can cause significant side effects.

Jiang, Y.-H., Jhang, J.-F., Ho, H.-C., Chiou, D.-Y

For instance, peptides like Ipamorelin and CJC-1295 are known to help increase energy levels, allowing you to push harder during workouts

doi: 10.2460/javma.229.9.1447